Direxion Daily S&P Biotech Bear 3X Shares
LABD
LABD
16 hedge funds and large institutions have $13.2M invested in Direxion Daily S&P Biotech Bear 3X Shares in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
68% less capital invested
Capital invested by funds: $41.8M → $13.2M (-$28.6M)
Holders
16
Holding in Top 10
–
Calls
$15.2M
Puts
$7.3M
Top Buyers
| 1 | +$1.15M | |
| 2 | +$782K | |
| 3 | +$521K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$489K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$173K |
Top Sellers
| 1 | -$8.48M | |
| 2 | -$7.13M | |
| 3 | -$4.22M | |
| 4 |
HF
HRT Financial
New York
|
-$1.82M |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$1.25M |